Skip to main content
×
Home
    • Aa
    • Aa

The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology

  • Wendy C. Burns (a1) and Merlin C. Thomas (a1)
Abstract

Common to all forms of chronic kidney disease is the progressive scarring of the tubulo-interstitial space, associated with the acquisition and accumulation of activated myofibroblasts. Many of these myofibroblasts are generated when tubular epithelial cells progressively lose their epithelial characteristics (cell–cell contact, microvilli, tight-junction proteins, apical–basal polarity) and acquire features of a mesenchymal lineage, including stress fibres, filopodia and augmented matrix synthesis. This process, known as epithelial to mesenchymal transition (EMT), plays an important role in progressive kidney disease. For EMT to occur in tubular cells, the transcriptional activation (and derepression) of genes required to sustain mesenchymal-type structures and functions (e.g. vimentin, α-smooth muscle actin) must occur alongside repression (or deactivation) of genes that act to maintain the epithelial phenotype (e.g. E-cadherin, bone morphogenic protein 7). Several factors have been suggested as potential initiators of EMT. With a few key exceptions, these triggers require the induction of transforming growth factor β (TGF-β) and downstream mediators, including SMADs, CTGF, ILK and SNAI1. Activation of TGF-β receptors is also able to stimulate a range of additional pathways (so-called non-SMAD activation), including RhoA, mitogen-activated protein kinase and phosphoinositide 3-kinase signalling cascades, that also contribute to EMT and renal fibrogenesis. This review examines in detail the molecular mediators of EMT in tubular cells and its potential role as a long-lasting mediator of metabolic stress.

Copyright
Corresponding author
*Corresponding author: Merlin C. Thomas, Baker IDI Heart and Diabetes Institute, P.O. Box 6492, Melbourne, VIC 8008, Australia. E-mail: merlin.thomas@bakeridi.edu.au
References
Hide All
1Yang J. and Liu Y. (2001) Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. American Journal of Pathology 159, 1465-1475
2Liu Y. (2004) Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. Journal of the American Society of Nephrology 15, 1-12
3Burns W. et al. CTGF plays a pivotal role in AGE induced tubular EMT: implications for diabetic renal disease. Journal of the American Society of Nephrology (in press)
4Iwano M. et al. (2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. Journal of Clinical Investigation 110, 341-350
5Oldfield M.D. et al. (2001) Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). Journal of Clinical Investigation 108, 1853-1863
6Kalluri R. and Neilson E.G. (2003) Epithelial-mesenchymal transition and its implications for fibrosis. Journal of Clinical Investigation 112, 1776-1784
7Rastaldi M.P. et al. (2002) Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney International 62, 137-146
8Zeisberg M. and Neilson E.G. (2009) Biomarkers for epithelial-mesenchymal transitions. Journal of Clinical Investigation 119, 1429-1437
9Hay E.D. and Zuk A. (1995) Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced. American Journal of Kidney Diseases 26, 678-690
10Acloque H. et al. (2009) Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. Journal of Clinical Investigation 119, 1438-1449
11Strutz F., Muller G.A. and Neilson E.G. (1996) Transdifferentiation: a new angle on renal fibrosis. Experimental Nephrology 4, 267-270
12Qi W. et al. (2005) Integrated actions of transforming growth factor-beta1 and connective tissue growth factor in renal fibrosis. American Journal of Physiology – Renal Physiology 288, F800-809
13Margetts P.J. et al. (2005) Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum. Journal of the American Society of Nephrology 16, 425-436
14Okada H. et al. (1997) Early role of Fsp1 in epithelial-mesenchymal transformation. American Journal of Physiology 273, F563-574
15Fan J.M. et al. (2001) Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro. American Journal of Kidney Diseases 37, 820-831
16Strutz F. et al. (2002) Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney International 61, 1714-1728
17Ha H. and Lee H.B. (2003) Reactive oxygen species and matrix remodeling in diabetic kidney. Journal of the American Society of Nephrology 14, S246-249
18Lan H.Y. (2003) Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. Current Opinion in Nephrology and Hypertension 12, 25-29
19Lee J.M. et al. (2006) The epithelial-mesenchymal transition: new insights in signaling, development, and disease. Journal of Cell Biology 172, 973-981
20Zavadil J. and Bottinger E.P. (2005) TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24, 5764-5774
21Yang J. and Liu Y. (2002) Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. Journal of the American Society of Nephrology 13, 96-107
22Zeisberg M. et al. (2001) Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. American Journal of Pathology 159, 1313-1321
23Massague J. and Wotton D. (2000) Transcriptional control by the TGF-beta/Smad signaling system. EMBO Journal 19, 1745-1754
24Bottinger E.P. and Bitzer M. (2002) TGF-beta signaling in renal disease. Journal of the American Society of Nephrology 13, 2600-2610
25Fan J.M. et al. (1999) Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney International 56, 1455-1467
26Wrana J.L. et al. (1992) TGF beta signals through a heteromeric protein kinase receptor complex. Cell 71, 1003-1014
27Wang Q.L. et al. (2010) Fuzheng Huayu recipe and vitamin E reverse renal interstitial fibrosis through counteracting TGF-beta1-induced epithelial-to-mesenchymal transition. Journal of Ethnopharmacology 127, 631-640
28Petersen M. et al. (2008) Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis. Kidney International 73, 705-715
29Schnaper H.W. et al. (2003) TGF-beta signal transduction and mesangial cell fibrogenesis. American Journal of Physiology – Renal Physiology 284, F243-252
30Phanish M.K. et al. (2006) The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbeta1 responses in human proximal-tubule epithelial cells. Biochemical Journal 393, 601-607
31Zavadil J. et al. (2004) Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO Journal 23, 1155-1165
32Sato M. et al. (2003) Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. Journal of Clinical Investigation 112, 1486-1494
33Piek E., Heldin C.H. and Ten Dijke P. (1999) Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB Journal 13, 2105-2124
34ten Dijke P., Miyazono K. and Heldin C.H. (2000) Signaling inputs converge on nuclear effectors in TGF-beta signaling. Trends in Biochemical Sciences 25, 64-70
35Itoh F. et al. (2001) Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads. EMBO Journal 20, 4132-4142
36Chung A.C. et al. (2009) Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice. Nephrology Dialysis Transplantation 24, 1443-1454
37Lan H.Y. et al. (2003) Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. Journal of the American Society of Nephrology 14, 1535-1548
38Li Y. et al. (2003) Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. Journal of Clinical Investigation 112, 503-516
39Li J.H. et al. (2002) Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation. Journal of the American Society of Nephrology 13, 1464-1472
40Carvajal G. et al. (2008) Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation. Kidney International 74, 585-595
41Fukasawa H. et al. (2004) Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice. Proceedings of the National Academy of Sciences of the United States of America 101, 8687-8692
42Schiffer M. et al. (2001) Apoptosis in podocytes induced by TGF-beta and Smad7. Journal of Clinical Investigation 108, 807-816
43Massague J. (2000) How cells read TGF-beta signals. Nature Reviews Molecular Cell Biology 1, 169-178
44Goto Y. et al. (2004) Augmented cytoplasmic Smad4 induces acceleration of TGF-beta1 signaling in renal tubulointerstitial cells of hereditary nephrotic ICGN mice with chronic renal fibrosis; possible role for myofibroblastic differentiation. Cell and Tissue Research 315, 209-221
45Oemar B.S. and Luscher T.F. (1997) Connective tissue growth factor. Friend or foe? Arteriosclerosis Thrombosis and Vascular Biology 17, 1483-1489
46Grotendorst G.R. (1997) Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine and Growth Factor Reviews 8, 171-179
47Burns W.C., Kantharidis P. and Thomas M.C. (2007) The role of tubular epithelial-mesenchymal transition in progressive kidney disease. Cells Tissues Organs 185, 222-231
48Burns W.C. et al. (2006) Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. Journal of the American Society of Nephrology 17, 2484-2494
49Peinado H., Quintanilla M. and Cano A. (2003) Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. Journal of Biological Chemistry 278, 21113-21123
50Okada H. et al. (2005) Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis. Journal of the American Society of Nephrology 16, 133-143
51Chen L. et al. (2006) Influence of connective tissue growth factor antisense oligonucleotide on angiotensin II-induced epithelial mesenchymal transition in HK2 cells. Acta Pharmacologica Sinica 27, 1029-1036
52Mori T. et al. (1999) Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: a mouse fibrosis model. Journal of Cellular Physiology 181, 153-159
53Yokoi H. et al. (2004) Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. Journal of the American Society of Nephrology 15, 1430-1440
54van Nieuwenhoven F.A. et al. (2005) Imbalance of growth factor signalling in diabetic kidney disease: is connective tissue growth factor (CTGF, CCN2) the perfect intervention point? Nephrology Dialysis Transplantation 20, 6-10
55Abdel Wahab N. and Mason R.M. (2004) Connective tissue growth factor and renal diseases: some answers, more questions. Current Opinion in Nephrology and Hypertension 13, 53-58
56Wahab N.A., Weston B.S. and Mason R.M. (2005) Modulation of the TGFbeta/Smad signaling pathway in mesangial cells by CTGF/CCN2. Experimental Cell Research 307, 305-314
57Wahab N.A., Weston B.S. and Mason R.M. (2005) Connective tissue growth factor CCN2 interacts with and activates the tyrosine kinase receptor TrkA. Journal of the American Society of Nephrology 16, 340-351
58Liu X.C. et al. (2007) Role of ERK1/2 and PI3-K in the regulation of CTGF-induced ILK expression in HK-2 cells. Clinica Chimica Acta 382, 89-94
59Nishida T. et al. (1998) Demonstration of receptors specific for connective tissue growth factor on a human chondrocytic cell line (HCS-2/8). Biochemical and Biophysical Research Communications 247, 905-909
60Segarini P.R. et al. (2001) The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor is a receptor for connective tissue growth factor. Journal of Biological Chemistry 276, 40659-40667
61Chen Y. et al. (2001) Connective tissue growth factor is secreted through the Golgi and is degraded in the endosome. Experimental Cell Research 271, 109-117
62Liu B.C. et al. (2008) Inhibition of integrin-linked kinase via a siRNA expression plasmid attenuates connective tissue growth factor-induced human proximal tubular epithelial cells to mesenchymal transition. American Journal of Nephrology 28, 143-151
63Thiery J.P. et al. (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890
64Ikenouchi J. et al. (2003) Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. Journal of Cell Science 116, 1959-1967
65Thuault S. et al. (2008) HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition. Journal of Biological Chemistry 283, 33437-33446
66Thuault S. et al. (2006) Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition. Journal of Cell Biology 174, 175-183
67Vincent T. et al. (2009) A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. Nature Cell Biology 11, 943-950
68Yokoyama K. et al. (2003) Increased invasion and matrix metalloproteinase-2 expression by Snail-induced mesenchymal transition in squamous cell carcinomas. International Journal of Oncology 22, 891-898
69Jorda M. et al. (2005) Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor. Journal of Cell Science 118, 3371-3385
70Derynck R. and Zhang Y.E. (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425, 577-584
71Kokudo T. et al. (2008) Snail is required for TGFbeta-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells. Journal of Cell Science 121, 3317-3324
72Zhang Y.E. (2009) Non-Smad pathways in TGF-beta signaling. Cell Research 19, 128-139
73Bolos V. et al. (2003) The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. Journal of Cell Science 116, 499-511
74Bhowmick N.A. et al. (2001) Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Molecular Biology of the Cell 12, 27-36
75Kolosionek E. et al. (2009) Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: the role of phosphodiesterase 4. Molecular Biology of the Cell 20, 4751-4765
76Bhowmick N.A. et al. (2003) TGF-beta-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrest. Proceedings of the National Academy of Sciences of the United States of America 100, 15548-15553
77Rodrigues-Diez R. et al. (2008) Pharmacological modulation of epithelial mesenchymal transition caused by angiotensin II. Role of ROCK and MAPK pathways. Pharmaceutical Research 25, 2447-2461
78Patel S. et al. (2005) RhoGTPase activation is a key step in renal epithelial mesenchymal transdifferentiation. Journal of the American Society of Nephrology 16, 1977-1984
79Rhyu D.Y. et al. (2005) Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. Journal of the American Society of Nephrology 16, 667-675
80Bakin A.V. et al. (2000) Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. Journal of Biological Chemistry 275, 36803-36810
81Zhu Q. et al. (2007) Dual role of SnoN in mammalian tumorigenesis. Molecular and Cellular Biology 27, 324-339
82Docherty N.G. et al. (2006) TGF-beta1-induced EMT can occur independently of its proapoptotic effects and is aided by EGF receptor activation. American Journal of Physiology – Renal Physiology 290, F1202-1212
83Winbanks C.E. et al. (2007) Role of the phosphatidylinositol 3-kinase and mTOR pathways in the regulation of renal fibroblast function and differentiation. International Journal of Biochemistry and Cell Biology 39, 206-219
84Morrissey J. et al. (2002) Transforming growth factor-beta induces renal epithelial jagged-1 expression in fibrotic disease. Journal of the American Society of Nephrology 13, 1499-1508
85Walsh D.W. et al. (2008) Co-regulation of Gremlin and Notch signalling in diabetic nephropathy. Biochimica et Biophysica Acta 1782, 10-21
86Yoshikawa M. et al. (2007) Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells. Journal of the American Society of Nephrology 18, 58-65
87Deheuninck J. and Luo K. (2009) Ski and SnoN, potent negative regulators of TGF-beta signaling. Cell Research 19, 47-57
88Miyazono K., Suzuki H. and Imamura T. (2003) Regulation of TGF-beta signaling and its roles in progression of tumors. Cancer Science 94, 230-234
89Zavadil J. et al. (2007) Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity. Cells Tissues Organs 185, 157-161
90Kato M. et al. (2007) MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proceedings of the National Academy of Sciences of the United States of America 104, 3432-3437
91Huang S.S. and Huang J.S. (2005) TGF-beta control of cell proliferation. Journal of Cellular Biochemistry 96, 447-462
92Hu K. et al. (2008) tPA protects renal interstitial fibroblasts and myofibroblasts from apoptosis. Journal of the American Society of Nephrology 19, 503-514
93Wang S.N., Lapage J. and Hirschberg R. (2001) Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. Journal of the American Society of Nephrology 12, 2392-2399
94Postlethwaite A.E., Shigemitsu H. and Kanangat S. (2004) Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis. Current Opinion in Rheumatology 16, 733-738
95Zeisberg M. et al. (2003) BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nature Medicine 9, 964-968
96Kondo M. et al. (2004) A role for Id in the regulation of TGF-beta-induced epithelial-mesenchymal transdifferentiation. Cell Death and Differentiation 11, 1092-1101
97Kowanetz M. et al. (2004) Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein. Molecular and Cellular Biology 24, 4241-4254
98Saika S. et al. (2006) Adenoviral gene transfer of BMP-7, Id2, or Id3 suppresses injury-induced epithelial-to-mesenchymal transition of lens epithelium in mice. American Journal of Physiology – Cell Physiology 290, C282-289
99Valcourt U. et al. (2005) TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Molecular Biology of the Cell 16, 1987-2002
100Zeisberg M., Shah A.A. and Kalluri R. (2005) Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. Journal of Biological Chemistry 280, 8094-8100
101Wang S. et al. (2003) Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney International 63, 2037-2049
102Yang J., Dai C. and Liu Y. (2005) A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. Journal of the American Society of Nephrology 16, 68-78
103Dai C. et al. (2004) Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice. Journal of the American Society of Nephrology 15, 2637-2647
104Cruzado J.M. et al. (2004) Regression of advanced diabetic nephropathy by hepatocyte growth factor gene therapy in rats. Diabetes 53, 1119-1127
105Brinkmann V. et al. (1995) Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells. Journal of Cell Biology 131, 1573-1586
106Weidner K.M. et al. (1990) Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. Journal of Cell Biology 111, 2097-2108
107Savagner P., Yamada K.M. and Thiery J.P. (1997) The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. Journal of Cell Biology 137, 1403-1419
108Zavadil J. et al. (2001) Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proceedings of the National Academy of Sciences of the United States of America 98, 6686-6691
109Eger A. et al. (2005) DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 24, 2375-2385
110Comijn J. et al. (2001) The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Molecular Cell 7, 1267-1278
111Guarino M., Tosoni A. and Nebuloni M. (2009) Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition. Human Pathology 40, 1365-1376
112Cheng S. et al. (2006) Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury. FASEB Journal 20, 1898-1900
113Boutet A. et al. (2006) Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. EMBO Journal 25, 5603-5613
114Marcussen N. (2000) Tubulointerstitial damage leads to atubular glomeruli: significance and possible role in progression. Nephrology Dialysis Transplantation 15 (Suppl 6), 74-75
115Pagtalunan M.E. et al. (1996) Atubular glomeruli in patients with chronic allograft rejection. Transplantation 61, 1166-1171
116Thomas M.C., Burns W.C. and Cooper M.E. (2005) Tubular changes in early diabetic nephropathy. Advances in Chronic Kidney Disease 12, 177-186
117Chalmers J. and Cooper M.E. (2008) UKPDS and the legacy effect. New England Journal of Medicine 359, 1618-1620
118Holman R.R. et al. (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. New England Journal of Medicine 359, 1577-1589
119Holman R.R. et al. (2008) Long-term follow-up after tight control of blood pressure in type 2 diabetes. New England Journal of Medicine 359, 1565-1576
120Ceriello A., Ihnat M.A. and Thorpe J.E. (2009) Clinical review 2: The “metabolic memory”: is more than just tight glucose control necessary to prevent diabetic complications? Journal of Clinical Endocrinology and Metabolism 94, 410-415
121Song J. (2007) EMT or apoptosis: a decision for TGF-beta. Cell Research 17, 289-290
Liu Y. (2010) New insights into epithelial-mesenchymal transition in kidney fibrosis. Journal of the American Society of Nephrology 21, 212-222
Zhang Y.E. (2009) Non-Smad pathways in TGF-beta signaling. Cell Research 19, 128-139
Runyan C.E. et al. (2009) Role of SARA (SMAD anchor for receptor activation) in maintenance of epithelial cell phenotype. Journal of Biological Chemistry 284, 25181-25189
Larsson O. et al. (2008) Fibrotic myofibroblasts manifest genome-wide derangements of translational control. PLoS One 3, e3220
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Expert Reviews in Molecular Medicine
  • ISSN: -
  • EISSN: 1462-3994
  • URL: /core/journals/expert-reviews-in-molecular-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 14
Total number of PDF views: 41 *
Loading metrics...

Abstract views

Total abstract views: 313 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 22nd October 2017. This data will be updated every 24 hours.